{{Rsnum
|rsid=7211818
|Gene=RPTOR
|Chromosome=17
|position=80715103
|Orientation=plus
|GMAF=0.2456
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=RPTOR
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 57.5 | 36.3 | 6.2
| HCB | 43.7 | 43.0 | 13.3
| JPT | 50.0 | 42.7 | 7.3
| YRI | 55.2 | 40.7 | 4.1
| ASW | 64.9 | 33.3 | 1.8
| CHB | 43.7 | 43.0 | 13.3
| CHD | 49.5 | 43.0 | 7.5
| GIH | 56.0 | 39.0 | 5.0
| LWK | 58.2 | 36.4 | 5.5
| MEX | 75.9 | 24.1 | 0.0
| MKK | 60.6 | 36.8 | 2.6
| TSI | 61.8 | 34.3 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19875696
|Title=Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}